Lijenta-M 2.5 mg+1000 mg (Tablet)
Unit Price: ৳ 16.00 (2 x 8: ৳ 256.00)
Strip Price: ৳ 128.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Linagliptin metformin hydrochloride |
| Company | Nipro jmi pharma ltd |
| Also available as |
Indications
- Adjunct to diet and exercise
- Improves glycemic control
- Type 2 diabetes mellitus
Pharmacology
- Inhibitor of DPP-4 enzyme
- Stimulates insulin release
- Decreases glucagon secretion
- Oral antihyperglycemic drug
- Lowers plasma glucose
- Improves insulin sensitivity
Dosage & Administration
- Individualized dosage
- Maximum recommended dose
- Dose escalation
- Immediate release tablet
- Extended release tablet
- Starting dose recommendations
Interaction
- Cationic drugs interaction
- Carbonic Anhydrase Inhibitors interaction
- Inducers of P-glycoprotein and CYP3A4 Enzymes interaction
- Drugs affecting glycemic control interaction
Contraindications
- Renal impairment
- Metabolic acidosis
- Hypersensitivity
Side Effects
- Nasopharyngitis
- Diarrhea
- Hypoglycemia
- Sulfonylureas interaction
Pregnancy & Lactation
- Caution during pregnancy
- Use only if clearly needed
- Caution during lactation
Precautions & Warnings
- Discontinue in lactic acidosis
- Postmarketing reports of acute pancreatitis
- Discontinue before radiologic studies or surgical procedures
- Monitor Vitamin B12 levels
- Caution with alcohol and other medicines
- Counseling for family members
- Travel precautions
- Emergency preparedness
- Hypoglycemia prevention and treatment
Overdose Effects
- Supportive measures
- Dialyzable overdose effects
- No dose-related clinical adverse drug reactions
- Hypoglycemia in Metformin overdose
- Lactic acidosis in Metformin overdose
Therapeutic Class
- Oral hypoglycemic preparations
Storage Conditions
- Cool & dry storage
- Below 30°C
- Protected from light & moisture
- Keep out of reach of children